这是描述信息
Location:
Homepage
/
/
Based on the reform, open a new path-the new logo of Hongqi Pharmaceutical made its debut in the "National Tuberculosis Hospital Management and Innovation Forum"

Based on the reform, open a new path-the new logo of Hongqi Pharmaceutical made its debut in the "National Tuberculosis Hospital Management and Innovation Forum"

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-12-20
  • Views:0

(Summary description)October 16, 2020, co-sponsored by Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance, China CDC Tuberculosis Prevention and Treatment Clinical Center, National Tuberculosis Hospital Alliance, Beijing Chest Hospital Affiliated to Capital Medical University

Based on the reform, open a new path-the new logo of Hongqi Pharmaceutical made its debut in the "National Tuberculosis Hospital Management and Innovation Forum"

(Summary description)October 16, 2020, co-sponsored by Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance, China CDC Tuberculosis Prevention and Treatment Clinical Center, National Tuberculosis Hospital Alliance, Beijing Chest Hospital Affiliated to Capital Medical University

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-12-20
  • Views:0
Information

October 16, 2020, co-sponsored by Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance, China CDC Tuberculosis Prevention and Treatment Clinical Center, National Tuberculosis Hospital Alliance, Beijing Chest Hospital Affiliated to Capital Medical University, Beijing Chest Hospital Tuberculosis Specialist Alliance, Hebei Province The 8th "National Tuberculosis Hospital Management and Innovation Forum" hosted by the Chest Hospital kicked off. More than 300 deans and experts from all over the country gathered in Shijiazhuang, Hebei, to provide suggestions for the construction and development of tuberculosis hospitals. In this conference, the new logo of Hongqi Pharmaceuticals was unveiled for the first time. The new logo implies that Hongqi Pharmaceuticals is the industry benchmark in the tuberculosis field. The red flag will fly throughout China and the world, opening a healthy door for mankind.

 

The opening ceremony of the forum was presided over by Li Liang, executive vice chairman of the Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance and vice president of Beijing Chest Hospital affiliated to Capital Medical University. Xu Shaofa, chairman of the Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance and dean of Beijing Chest Hospital, Capital Medical University, delivered an opening speech. Dean Xu Shaofa and Vice Dean Li Liang conducted in-depth discussions on "Training Talents of Tuberculosis Hospitals" and "Development and Cooperation of Tuberculosis Hospitals in the New Era" respectively. Dean Xu emphasized that the cultivation of hospital talents is very important, and at the same time, there must be correct methods for selecting, training and managing talents. In President Li’s report, it was mentioned that the development of hospitals is inseparable from the support of enterprises. The member units of the Innovation Alliance have played an important role in the development of national tuberculosis hospitals. At the same time, the drugs produced by the member units of the Innovation Alliance are also clinically recognized. Quality products.

 
 

In the next meeting, the latest scientific research results such as China's NTM epidemiological survey results, the tuberculosis imaging database AI platform project, and the I series of smart products were also released, which caused a strong response on the scene and also heralded the progress in the field of tuberculosis diagnosis. The theme of this forum is "Planning and Development". The report also covers the interpretation and practice sharing of policies formulated by the hospital’s 14th Five-Year Plan, reflections on talent training and construction development of designated tuberculosis hospitals, and the work of prevention and control of the new crown epidemic on us. The enlightenment of TB prevention and control, the analysis of the difficulties and key tasks of tuberculosis prevention and control, the combination of peacetime and warfare and the coordination of prevention and control of specialized hospitals in the post-epidemic era, the design and planning ideas of infectious hospitals, etc.

During the meeting, the leaders of the Innovation Alliance also paid attention to and condoned the representatives of various enterprises, and gave suggestions on the development and product promotion of various enterprises. Dean Li also put forward suggestions for Hongqi's product structure and corporate development. Du Jian, secretary-general of the Innovation Alliance, also mentioned in the work summary report that the Innovation Alliance should strengthen cooperation with enterprises to jointly promote the construction of tuberculosis hospitals and the development of tuberculosis business. At the same time, he also mentioned the young eagle project jointly organized with Hongqi Pharmaceutical. The contribution to the training of young doctors, especially this year's Young Eagle Class, will show and enhance the talents of young doctors on a larger scale and contribute to the cause of tuberculosis diagnosis and treatment.

 
 
 
 

Hongqi Pharmaceutical also actively participated in this conference. The new logo of Hongqi Pharmaceutical was displayed in the main background of the conference, the materials in the information bag and the booth. This forum brings together top managers and experts across the country, so the debut of the new logo at such a conference also symbolizes Hongqi Pharmaceutical's benchmark position in the tuberculosis field and Hongqi's determination to escort the health of tuberculosis patients in the future. Based on reform and opening a new path, Hongqi Pharmaceuticals will adhere to the concept of everything for patient health to build a world-class tuberculosis pharmaceutical company and open a healthy door for tuberculosis patients.

Scan the QR code to read on your phone

Copyright hongqipharma.com All rights reserved     Powered by:300.cn Shenyang    辽icp备12005917号    (辽)-非经营性-2018-0012 

Add:Shenyang Hunnan New District envelope 6th Street    Tel:024-23786268-8012  Fax:024-23786263